APOLLO ENDOSURGERY, INC.

Profile

Company Names

APOLLO ENDOSURGERY, INC.
LPATH, INC

Addresses

1120 SOUTH CAPITAL OF TX HWY, BUILDING 1 SUITE 300, AUSTIN, TX 78746

4025 SORRENTO VALLEY BLVD., SAN DIEGO, CA 92121-1404

6335 FERRIS SQUARE, SUITE A, SAN DIEGO, CA 92121

Phone Numbers

512-279-5100
858-678-0800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$62,394,701.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-07-21 
$24,982,480.00 
$24,982,480.00 
$0.00 
Equity 
3
2019-08-12 
$20,000,000.00 
$20,000,000.00 
$0.00 
Debt 
2
2014-09-25 
$12,527,521.00 
$12,527,521.00 
$0.00 
Equity 
1
2010-11-16 
$4,884,700.00 
$5,000,000.00 
$115,300.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICK 
 
ANDERSON 
DIRECTOR
IDEV TECHNOLOGIES INC   |  TRYTON MEDICAL INC   |  CAMERON HEALTH, INC.   |  CARDIVA MEDICAL INC   |  INSITE VISION INC   |  INTERSECT ENT, INC.   |  APOLLO ENDOSURGERY INC   |  APOLLO ENDOSURGERY US INC   |  CARDIVA MEDICAL, INC.   |  APOLLO ENDOSURGERY, INC.
GARY 
J G 
ATKINSON 
EXECUTIVE OFFICER
LPATH, INC
JOHN 
 
BARR 
DIRECTOR
AP PHARMA INC /DE/   |  VALERITAS INC   |  APOLLO ENDOSURGERY, INC.   |  NORSEMAN CAPITAL LTD.
STEFANIE 
 
CAVANAUGH 
EXECUTIVE OFFICER
APOLLO ENDOSURGERY US INC   |  APOLLO ENDOSURGERY, INC.   |  ASPIRA WOMEN-S HEALTH INC.   |  ASPIRA WOMEN-S HEALTH INC.
MATTHEW 
S. 
CRAWFORD 
DIRECTOR
PTV SCIENCES III, L.P.   |  APOLLO ENDOSURGERY INC   |  PTV SPECIAL OPPORTUNITIES I, L.P.   |  APOLLO ENDOSURGERY, INC.   |  PTV CM SPV, LLC
JEFFREY 
A 
FERRELL 
DIRECTOR
LPATH, INC
JEFFREY 
A. 
FERRELL 
DIRECTOR
ATHYRIUM PARTNERS, LP   |  LPATH, INC   |  ATHYRIUM OPPORTUNITIES FUND II-B MASTER LP   |  ATHYRIUM OPPORTUNITIES FUND II (NON-US) LP   |  ATHYRIUM OPPORTUNITIES FUND II LP   |  PROGENITY, INC.   |  ATHYRIUM OPPORTUNITIES FUND III (NON-US) B LP   |  ATHYRIUM OPPORTUNITIES FUND III (NON-US) A LP   |  ATHYRIUM OPPORTUNITIES FUND III LP   |  ATHYRIUM HEALTHCARE STRATEGIC INCOME + GROWTH IDF LLC   |  ATHYRIUM OPPORTUNITIES FUND IV (NON-US) LP   |  ATHYRIUM OPPORTUNITIES FUND IV LP   |  ATHYRIUM OPPORTUNITIES FUND IV MASTER (NON-US) LP   |  ATHYRIUM OT LP
CHRISTOPHER 
 
GOSTOUT 
EXECUTIVE OFFICER
APOLLO ENDOSURGERY, INC.
CHRISTOPHER 
J. 
GOSTOUT 
EXECUTIVE OFFICER
APOLLO ENDOSURGERY, INC.
DANIEL 
L. 
KISNER 
DIRECTOR
SEQUOIA PHARMACEUTICALS INC   |  LPATH, INC   |  HISTOGEN INC.
CHARLES 
A 
MATHEWS 
DIRECTOR
LPATH, INC
CHARLES 
A. 
MATHEWS 
DIRECTOR
LPATH, INC
WILLIAM 
D. 
MCCLELLAN 
DIRECTOR
APOLLO ENDOSURGERY, INC.
R. KENT 
 
MCGAUGHY, JR. 
DIRECTOR
APOLLO ENDOSURGERY INC   |  APOLLO ENDOSURGERY US INC   |  APOLLO ENDOSURGERY, INC.
JOHN 
 
MOLESPHINI 
EXECUTIVE OFFICER
APOLLO ENDOSURGERY, INC.
TODD 
 
NEWTON 
EXECUTIVE OFFICER, DIRECTOR
APOLLO ENDOSURGERY US INC   |  APOLLO ENDOSURGERY, INC.
DAVID 
C. 
PACITTI 
DIRECTOR
APOLLO ENDOSURGERY, INC.
SCOTT 
R 
PANCOAST 
EXECUTIVE OFFICER, DIRECTOR
LPATH, INC
SCOTT 
R. 
PANCOAST 
EXECUTIVE OFFICER, DIRECTOR
LPATH, INC
DANIEL 
H 
PETREE 
DIRECTOR
LPATH, INC
DANIEL 
H. 
PETREE 
DIRECTOR
LPATH, INC
BRUCE 
 
ROBERTSON 
DIRECTOR
APOLLO ENDOSURGERY INC   |  CARDIOFOCUS, INC.   |  WILD STREAM EXPLORATION INC.   |  CEREPHEX CORP   |  ICONIC THERAPEUTICS INC   |  SOFT-TEX HOLDINGS INC.   |  RXSIGHT, INC.   |  INTACT VASCULAR, INC.   |  APOLLO ENDOSURGERY, INC.   |  ZERIGO HEALTH, INC.
BRET 
 
SCHWARTZHOFF 
EXECUTIVE OFFICER
APOLLO ENDOSURGERY US INC   |  APOLLO ENDOSURGERY, INC.
JULIE 
 
SHIMER 
DIRECTOR
APOLLO ENDOSURGERY, INC.
DONALD 
R 
SWORTWOOD 
DIRECTOR
LPATH, INC
DONALD 
R. 
SWORTWOOD 
DIRECTOR
LPATH, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-07-30
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2020-07-21 
2019-08-27
D
Link
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Debt 
2019-08-12 
2014-10-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-09-25 
2010-12-01
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2010-11-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CRAIG-HALLUM CAPITAL GROUP LLC
121395
NONE
NONE
MAXIM GROUP, LLC
120708
NONE
NONE
GRIFFIN SECURITIES INC
NONE
NONE
NONE
MUSKET RESEARCH ASSOCIATES INC
NONE
NONE
NONE
ANDREW GARRETT INC
NONE